Why This UTI Fund-Backed Midcap Stock Hit 52-Week Today

Share price of Poly Medicure surged over 9% on Wednesday to hit a new 52-week high of ₹1,575.

What Happened: Shares of the healthcare company are upbeat as Investec initiated coverage on the stock with a ‘buy’ rating. The brokerage has set a price target of ₹1,690, which indicates an around 17% upside from the stock’s last closing price of ₹1,438.35.

See Also: Why Are Vodafone Idea Shares Jumping Today?

The firm said that the current macro environment is conducive to the company’s long-term growth. The firm added that the company’s ongoing capex will also double its capacities. The brokerage expects the company’s sales, EBITDA and PAT to grow at CAGRs of (compound annual growth rate) of 22%, 29%, and 31% respectively.

The analyst’s update helped the UTI Healthcare Fund-backed stock to continue making gains for the third straight session. UTI Healthcare Fund owns a 2.84% stake in the company.

Price Action: Poly Medicure’s share price was up 7.41% to trade at ₹745 in early trade on Wednesday.

Read Next: Why Tata Motors Shares Are Upbeat Today

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Posted In: Price TargetInitiationAnalyst RatingsMoversTrading IdeasPoly Medicure